Lotte Chemical Titan Holding Berhad (KLSE:LCTITAN)
Malaysia · Delayed Price · Currency is MYR 0.3150
+0.0150 (5.00%)
At close: Aug 10, 2026
KLSE:LCTITAN Income Statement
Financials in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 10,651 | 7,941 | 7,435 | 7,646 | 10,019 | 9,831 | |
Revenue Growth | 59.77% | 6.81% | -2.76% | -23.68% | 1.91% | 42.45% |
Cost of Revenue | 11,328 | 8,718 | 8,080 | 8,283 | 10,816 | 8,542 |
Gross Profit | -677.65 | -776.31 | -645.45 | -637.06 | -797.25 | 1,289 |
Selling, General & Admin | 308.85 | 254.96 | 228.42 | 242.36 | 223.46 | 247.59 |
Other Operating Expenses | 4.61 | -18.54 | -44.8 | -9.24 | -5.91 | -8.28 |
Operating Expenses | 313.46 | 236.41 | 183.62 | 233.11 | 217.55 | 239.31 |
Operating Income | -991.11 | -1,013 | -829.07 | -870.17 | -1,015 | 1,050 |
Interest Expense | -618.72 | -247.58 | -37.25 | -15.55 | -2.12 | -2.49 |
Interest & Investment Income | 28.67 | 17.76 | 15.87 | 22.56 | 50.12 | 52.54 |
Earnings From Equity Investments | 15.63 | -54.67 | -192.32 | -117.27 | 7.64 | 203.14 |
Currency Exchange Gain (Loss) | -59.42 | -28.75 | 435.22 | -4.3 | -19.55 | 31.24 |
Other Non Operating Income (Expenses) | -30.99 | -31.06 | -21.65 | -14.83 | -22.84 | -11.69 |
EBT Excluding Unusual Items | -1,656 | -1,357 | -629.2 | -999.57 | -1,002 | 1,323 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 10.19 |
Asset Writedown | -1,339 | -1,339 | -940.23 | - | - | - |
Pretax Income | -2,995 | -2,696 | -1,569 | -999.57 | -1,002 | 1,333 |
Income Tax Expense | 19.6 | 8.6 | -271.49 | -186.84 | -256.49 | 291.98 |
Earnings From Continuing Operations | -3,015 | -2,705 | -1,298 | -812.73 | -745.06 | 1,041 |
Minority Interest in Earnings | 908.82 | 597.03 | 34.48 | 32.44 | 14 | -0.84 |
Net Income | -2,106 | -2,108 | -1,263 | -780.29 | -731.06 | 1,040 |
Net Income to Common | -2,106 | -2,108 | -1,263 | -780.29 | -731.06 | 1,040 |
Net Income Growth | - | - | - | - | - | 599.93% |
Shares Outstanding (Basic) | 2,277 | 2,278 | 2,278 | 2,278 | 2,278 | 2,276 |
Shares Outstanding (Diluted) | 2,277 | 2,278 | 2,278 | 2,278 | 2,278 | 2,276 |
Shares Change | 0.00% | - | - | - | 0.08% | 0.12% |
EPS (Basic) | -0.92 | -0.93 | -0.55 | -0.34 | -0.32 | 0.46 |
EPS (Diluted) | -0.92 | -0.93 | -0.55 | -0.34 | -0.32 | 0.46 |
EPS Growth | - | - | - | - | - | 599.11% |
Free Cash Flow | -1,705 | -2,505 | -3,533 | -7,129 | -4,687 | 718.6 |
Free Cash Flow Per Share | -0.75 | -1.10 | -1.55 | -3.13 | -2.06 | 0.32 |
Dividend Per Share | - | - | - | - | - | 0.210 |
Dividend Growth | - | - | - | - | - | 542.20% |
Gross Margin | -6.36% | -9.78% | -8.68% | -8.33% | -7.96% | 13.11% |
Operating Margin | -9.31% | -12.75% | -11.15% | -11.38% | -10.13% | 10.68% |
Profit Margin | -19.77% | -26.54% | -16.99% | -10.21% | -7.30% | 10.58% |
Free Cash Flow Margin | -16.01% | -31.54% | -47.52% | -93.24% | -46.78% | 7.31% |
EBITDA | -345.67 | -547.31 | -334.96 | -381.29 | -451.76 | 1,584 |
EBITDA Margin | -3.25% | -6.89% | -4.50% | -4.99% | -4.51% | 16.12% |
D&A For EBITDA | 645.44 | 465.42 | 494.11 | 488.88 | 563.04 | 534.57 |
EBIT | -991.11 | -1,013 | -829.07 | -870.17 | -1,015 | 1,050 |
EBIT Margin | -9.30% | -12.75% | -11.15% | -11.38% | -10.13% | 10.68% |
Effective Tax Rate | - | - | - | - | - | 21.91% |